Aberrant CpG Island Hypermethylation of Chronic Gastritis, in Relation to Aging, Gender, Intestinal Metaplasia, and Chronic Inflammation

作者: Gyeong Hoon Kang , Hyeon Joo Lee , Kyu Sang Hwang , Sun Lee , Jae-Hoon Kim

DOI: 10.1016/S0002-9440(10)63511-0

关键词:

摘要: Aberrant hypermethylation of promoter CpG islands is an important mechanism for the inactivation tumor suppressor genes. island occurs in relation to tumorigenesis or aging. Gastric cancer one tumors with a high level aberrant methylation. However, data on methylation status normal gastric mucosa has been very limited. The present study attempted compare nonneoplastic mucosa, using clinicopathological parameters, including age, gender, Helicobacter pylori (H. pylori), acute and chronic inflammation, intestinal metaplasia. Two hundred sixty-eight samples were studied 11 genes (COX-2, DAP-kinase, E-cadherin, GSTP1, MGMT, hMLH1, p14, p16, THBS1, TIMP3, RASSF1A), methylation-specific PCR. was found 53.7, 41, 37.7, 23.1, 18.7, 10.9, 10, 4.1, 3.4, 1.7, 0.4% COX-2, hMLH1 RASSF1A, respectively. Five (DAP-kinase, TIMP-3) showed general progressive increase frequency as function aging, whereas other RASSF1A) rarely methylated. Male patients higher numbers methylated than females (3.2 vs. 2.1, respectively, P = 0.002). Gastritis marked metaplasia, those without (3.7 2.6, 0.021). infiltration mononuclear cells displayed mild moderate (3.4 2.5 2.5, < 0.05). Our results demonstrated that many are stomach suggested male inflammation closely associated increased samples.

参考文章(37)
Peter L. Jones, Gert Jan C. Veenstra, Paul A. Wade, Danielle Vermaak, Stefan U. Kass, Nicoletta Landsberger, John Strouboulis, Alan P. Wolffe, Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nature Genetics. ,vol. 19, pp. 187- 191 ,(1998) , 10.1038/561
Stephen B. Baylln, James G. Herman, Jeremy R. Graff, Paula M. Vertino, Jean-Pierre Issa, ALTERATIONS IN DNA METHYLATION : A FUNDAMENTAL ASPECT OF NEOPLASIA Advances in Cancer Research. ,vol. 72, pp. 141- 196 ,(1998) , 10.1016/S0065-230X(08)60702-2
Peter A Jones, Peter W Laird, Cancer-epigenetics comes of age Nature Genetics. ,vol. 21, pp. 163- 167 ,(1999) , 10.1038/5947
Stephen J. Meltzer, Romina M. Magno, Duane T. Smoot, Yulan Cheng, Keith T. Wilson, Mahmood Akhtar, Hassan Ashktorab, Promoter methylation regulates Helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epithelial cells. Cancer Research. ,vol. 61, pp. 2399- 2403 ,(2001)
Rachel A. Katzenellenbogen, Stephen B. Baylin, James G. Herman, Hypermethylation of the DAP-Kinase CpG Island Is a Common Alteration in B-Cell Malignancies Blood. ,vol. 93, pp. 4347- 4353 ,(1999) , 10.1182/BLOOD.V93.12.4347.412K31_4347_4353
Gabriel Capella, Minoru Toyota, Manel Esteller, Stephen B. Baylin, Miguel Angel Peinado, James G. Herman, Silvia Tortola, Hypermethylation-associated Inactivation of p14ARF Is Independent of p16INK4a Methylation and p53 Mutational Status Cancer Research. ,vol. 60, pp. 129- 133 ,(2000)
Kwok-Wai Lo, Joseph Kwong, Angela Bik-Yu Hui, Sylvia Yat-Yee Chan, Ka-Fai To, Andrew Siu-Chung Chan, Lillian Shuk-Nga Chow, Peter ML Teo, Philip J Johnson, Dolly Poon Huang, None, High Frequency of Promoter Hypermethylation of RASSF1A in Nasopharyngeal Carcinoma Cancer Research. ,vol. 61, pp. 3877- 3881 ,(2001)
Manel Esteller, Manel Esteller, Stephen B. Baylin, James G. Herman, Paul G. Corn, A Gene Hypermethylation Profile of Human Cancer Cancer Research. ,vol. 61, pp. 3225- 3229 ,(2001)
Xinsheng Nan, Huck-Hui Ng, Colin A. Johnson, Carol D. Laherty, Bryan M. Turner, Robert N. Eisenman, Adrian Bird, Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex Nature. ,vol. 393, pp. 386- 389 ,(1998) , 10.1038/30764
Y W Lee, C B Klein, B Kargacin, K Salnikow, J Kitahara, K Dowjat, A Zhitkovich, N T Christie, M Costa, Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens. Molecular and Cellular Biology. ,vol. 15, pp. 2547- 2557 ,(1995) , 10.1128/MCB.15.5.2547